At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,299 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
In Brief
An observational study for Diabetes Mellitus, Type 2. Completed, enrolled 4,299 participants across 153 sites in 19 countries.
Detailed Summary
The purpose of this study is to identify specific patient, physician, and health system related factors associated with the progression to a more intensive regimen from initial insulin therapy for patients with type 2 diabetes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesArgentina, Brazil, Canada, China, Germany, India, Israel, Italy, Japan, Mexico, Puerto Rico, Russia, Saudi Arabia, South Korea, Spain, Turkey (Türkiye), United Arab Emirates, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2011
Primary CompletionSep 2015
TodayJul 2026
First PostedJul 25, 2011
Enrollment StartJul 1, 2011
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 14.9 years ago